Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / ADMA Biologics faces class action
Business class action

ADMA Biologics faces class action

Analysis based on 6 articles · First reported May 08, 2026 · Last updated May 14, 2026

Sentiment
-20
Attention
2
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is impacted by the potential financial and reputational damage to ADMA Biologics due to the allegations of misleading business practices and the ensuing class action lawsuit. Investors in ADMA Biologics may face losses, while Rosen Law Firm stands to gain from representing affected shareholders.

Biotechnology Legal Services
Event Summary

Rosen Law Firm has announced an investigation into ADMA Biologics following allegations by Culper Research that ADMA Biologics engaged in channel stuffing to inflate revenue growth. These allegations, published by Investing.com on March 24, 2026, caused ADMA Biologics stock to fall by 16.6%. Rosen Law Firm is preparing a class action lawsuit to recover investor losses for shareholders who purchased ADMA Biologics securities, claiming the company may have issued materially misleading business information to the investing public.

Key Actions
95 ADMA Biologics stock declined
90 Culper Research published report ADMA Biologics
85 Rosen Law Firm announced investigation ADMA Biologics
Entities Involved
stock
ADMA Biologics
ADMA Biologics is facing a class action lawsuit due to allegations of issuing materially misleading business information and engaging in channel stuffing, which caused its stock to fall 16.6%.
Importance 100 Sentiment -30
priv
Rosen Law Firm
Rosen Law Firm is investigating potential securities claims against ADMA Biologics and is preparing a class action lawsuit on behalf of affected shareholders.
Importance 80 Sentiment 20
priv
Culper Research
Culper Research is the short seller that released a report alleging ADMA Biologics engaged in channel stuffing, which led to the stock plunge and subsequent legal action.
Importance 60 Sentiment 10
per
Lawrence Rosen
Lawrence Rosen is a founding partner of Rosen Law Firm, which is leading the investigation and class action against ADMA Biologics.
Importance 20 Sentiment 10
per
Philip Kim
Philip Kim is an attorney at Rosen Law Firm, involved in the class action against ADMA Biologics.
Importance 20 Sentiment 10
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.